EPIRUS BIOPHARMACEUTICALS IN's ticker is EPRSQ and the CUSIP is 29428P107. A total of 32 filers reported holding EPIRUS BIOPHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $203,000 | -83.2% | 449,061 | 0.0% | 0.00% | – |
| Q1 2016 | $1,208,000 | -9.9% | 449,061 | +3.4% | 0.00% | – |
| Q4 2015 | $1,341,000 | -99.1% | 434,144 | -91.7% | 0.00% | -100.0% |
| Q3 2015 | $151,168,000 | +7146.8% | 5,204,527 | +1324.3% | 0.01% | – |
| Q2 2015 | $2,086,000 | -29.3% | 365,408 | +10.9% | 0.00% | – |
| Q1 2015 | $2,949,000 | +539.7% | 329,420 | +304.7% | 0.00% | – |
| Q4 2014 | $461,000 | +3.8% | 81,408 | +32.1% | 0.00% | – |
| Q3 2014 | $444,000 | – | 61,645 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|